Join
Live feed
·
INSIDERFilingvia Quantisnow
Castle Biosciences Inc. logo

Chief Financial Officer Stokes Frank sold $168,375 worth of shares (4,496 units at $37.45), decreasing direct ownership by 8% to 50,326 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CSTL (Castle Biosciences Inc.) and more on Quantisnow.

Chief Financial Officer Stokes Frank sold $168,375 worth of shares (4,496 units at $37.45), decreasing direct ownership by 8% to 50,326 units (SEC Form 4) | Quantisnow